A detailed history of Gratus Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gratus Wealth Advisors, LLC holds 1,721 shares of LLY stock, worth $1.37 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,721
Previous 1,287 33.72%
Holding current value
$1.37 Million
Previous $1.1 Billion 40.1%
% of portfolio
0.25%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$772.14 - $960.02 $335,108 - $416,648
434 Added 33.72%
1,721 $1.55 Billion
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $82,635 - $103,630
114 Added 9.72%
1,287 $1.1 Billion
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $123,177 - $164,794
-208 Reduced 15.06%
1,173 $875 Million
Q4 2023

May 09, 2024

BUY
$525.19 - $619.13 $725,287 - $855,018
1,381 New
1,381 $805 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gratus Wealth Advisors, LLC Portfolio

Follow Gratus Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Wealth Advisors, LLC with notifications on news.